Genzyme which has struggled with manufacturing problems of its top products, said it would expand operations in Geel, Belgium, to support its drugs for Pompe disease. Genzyme, which is the target of an $18.5 billion takeover bid by France's Sanofi-Aventis, said it would build an additional manufacturing plant in Geel to support the long-term growth of its drugs, Myozyme and Lumizyme.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Oxea is returning to its old name and its roots.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Jens Birgersson becomes new Brenntag CEO
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
